Keywords: lilly, resubmits, cymbalta, snda, drug, major, eli

Lilly resubmits Cymbalta sNDA for

Article | 05 June 2009

Print This

US drug major Eli Lilly has resubmitted its supplemental New Drug Application for Cymbalta (duloxetine HCl) for the management of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in